title: Raltegravir in the prevention of mother-to-child transmission of HIV-1:  effective transplacental transfer and delayed plasma clearance observed in preterm neonates.
authors.forename: Aseel
authors.initials: A
authors.lastname: Hegazi
authors.forename: Denise
authors.initials: D
authors.lastname: Mc Keown
authors.forename: Katja
authors.initials: K
authors.lastname: Doerholt
authors.forename: Sheila
authors.initials: S
authors.lastname: Donaghy
authors.forename: Syed T
authors.initials: ST
authors.lastname: Sadiq
authors.forename: Phillip
authors.initials: P
authors.lastname: Hay
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood / Q000378:metabolism*; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D011295:Prenatal Care / Q000379:methods*; D011760:Pyrrolidinones / Q000008:administration & dosage* / Q000494:pharmacology; D000068898:Raltegravir Potassium
chemical_list: D019380:Anti-HIV Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium